© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists
REVIEW
BEST PRACTICE NO 181
Best Practice No 181
Chemical pathology clinical investigation and management of nephrolithiasis
Correspondence to:
Correspondence to:
Professor T M Reynolds
Clinical Chemistry Department, Queens Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, UK; tim.reynolds{at}burtonh-tr.wmids.nhs.uk
Renal stones have afflicted humans for millennia but there is still no solution to this problem. This review discusses the laboratory and metabolic aspects of the clinical management of patients with renal stones, both primary and secondary in origin. First, non-pharmacological interventions such as increased fluid intake, decreased protein consumption, dietary changes in sodium, calcium, oxalate, potassium, purine, vitamins, and essential fatty acids are considered. Then specific pharmacological treatment to modify urine calcium, oxalate, urate, citrate, and acidity are considered. Finally, more unusual types of stone are examined.
Keywords: nephrolithiasis; calcium oxalate; clinical management; cystinuria; uric acid
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
